Relapse prophylaxis and early recognition of pelvic organ prolapse in primary medical care organizations

Not Applicable

Completed

• Conditions: Prevention of recurrence of genital prolapse after surgical treatment; Nervous System Diseases

• Registration Number: ISRCTN23741622
• Lead Sponsor: Kazakhstan Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-07-31
• Study Start: 2023-01-30
• Last Update Posted: 27 March 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

1. Anterior and posterior vaginal wall prolapse stage II, according to the Pelvic Organ Prolapse Quantification System (POP-Q) classification and stress-induced urinary incontinence stage III, which was determined by the classification of D.V. Kahn
2. Aged 45 years old and under
3. History of two or more labours
4. No consent for conservative treatment
5. No consent for use of vaginal synthetic prostheses, including urethral sling
6. No history of conservative treatment of prolapse, including pelvic floor muscles training
7. No history of metabolic diseases (diabetes mellitus, obesity, metabolic syndrome, thyroid gland disorders, calcium phosphate metabolism disorders)

Exclusion Criteria

1. Urgent or combined urinary incontinence
2. Contraindications to surgical treatment and anaesthesia (general and regional anaesthesia: spinal, epidural anaesthesia)
3. Acute or chronic inflammatory diseases, acute phase of infectious diseases, malignant tumours, anaemia, benign ovarian and/or uterine tumours, pregnancy, haemorrhoids stage 3 and 4, decompensated chronic diseases, thrombosis and multiple drug allergies

Study & Design

• Study Type: Interventional
• Study Design: Not specified